Used for: Lowering the risk of infection during chemotherapy · Faster white blood cell recovery after AML chemotherapy · Low white blood cells after a bone marrow transplant · Collecting your own stem cells from the blood · Severe neutropenia (low white blood cells) · High-dose radiation exposure (acute radiation syndrome) · 5 more
How to pay the least
Ask for the cash price
Releuko
Releuko is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.
What to do
Ask your pharmacy for Releuko’s cash price, and one or two other pharmacies too.
Releuko’s savings card works only with insurance from a job or one you bought.
Other ways
Free from the maker, if you qualify Amneal Biosciences Patient Assistance Program. Or call 1-877-764-9021.
From the maker’s offer on amnealbiosciences.com, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Maker’s card or discount card?
A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.
With a free discount coupon
Optum Perks, Optum’s free discount coupon, lists these prices for Releuko without insurance. Show the coupon from its page at the pharmacy; it can’t be used with insurance.
From Optum Perks, read November 17, 2026, with no location set. Its page opens on this dose; other doses and pharmacies near you are priced there too. With insurance, check your co-pay first: it may be lower.
Authorized generic
There isn’t one.
Not soldThere isn’t one
Regular generic
Releuko is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.
Not soldAsk the pharmacy
What it’s used for
Lowering the risk of infection during chemotherapy
Faster white blood cell recovery after AML chemotherapy
RELEUKO is a leukocyte growth factor indicated to:
Decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti- cancer drugs associated with a significant incidence of severe neutropenia with fever.
Reduce the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia (AML).
Reduce the duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation (BMT).
Mobilize autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis
Reduce the incidence and duration of sequelae of severe neutropenia (e.g., fever‚ infections‚ oropharyngeal ulcers) in symptomatic patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia.
Increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome)
Source: the FDA label for Releuko (Amneal Pharmaceuticals LLC), April 24, 2025. Full label on DailyMed
Good to know
“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/releuko/